{ "disease": "wilms-tumor", "label": "Wilms tumour", "url": "https://usebiotransfer.org/disease/wilms-tumor/", "built": "2026-09-16", "facts_hash": { "answers": "26629e2268a4", "targets": "059bb3b9c6fa" }, "sources": { "targets": "Open Targets Platform GraphQL API v4", "trials": "ClinicalTrials.gov API v2" }, "retrieved": { "targets": "2026-09-16", "trials": "2026-09-16" }, "query": { "endpoint": "https://clinicaltrials.gov/api/v2/studies", "shape": "query.cond=&query.intr=&pageSize=200", "active_statuses": [ "ACTIVE_NOT_RECRUITING", "ENROLLING_BY_INVITATION", "NOT_YET_RECRUITING", "RECRUITING" ], "dedup": "by NCT id across synonyms", "study_types": "interventional counted in headline; observational reported separately", "known_floor": "trials naming an antigen only by product code are not retrieved by an intervention-name search" }, "targets": [ { "symbol": "WT1", "ensembl": "ENSG00000184937", "n_drug_entries": 2, "n_distinct_drugs": 2, "drugs": { "GALINPEPIMUT-S": "PHASE_3", "OMBIPEPIMUT-S": "PHASE_3" }, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "PR", "bucket": "UniProt Ubiquitination" }, { "modality": "OC", "bucket": "Advanced Clinical" } ] }, { "symbol": "CTNNB1", "ensembl": "ENSG00000168036", "n_drug_entries": 1, "n_distinct_drugs": 1, "drugs": { "PRI-724": "PHASE_2" }, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "SM", "bucket": "Structure with Ligand" }, { "modality": "SM", "bucket": "High-Quality Ligand" }, { "modality": "SM", "bucket": "Druggable Family" }, { "modality": "AB", "bucket": "UniProt loc high conf" }, { "modality": "AB", "bucket": "GO CC high conf" }, { "modality": "AB", "bucket": "Human Protein Atlas loc" }, { "modality": "PR", "bucket": "UniProt Ubiquitination" }, { "modality": "PR", "bucket": "Database Ubiquitination" }, { "modality": "PR", "bucket": "Half-life Data" }, { "modality": "PR", "bucket": "Small Molecule Binder" }, { "modality": "OC", "bucket": "Advanced Clinical" } ] }, { "symbol": "AMER1", "ensembl": "ENSG00000184675", "n_drug_entries": 0, "n_distinct_drugs": 0, "drugs": {}, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "AB", "bucket": "GO CC high conf" }, { "modality": "AB", "bucket": "UniProt loc med conf" }, { "modality": "AB", "bucket": "Human Protein Atlas loc" }, { "modality": "PR", "bucket": "Database Ubiquitination" } ] }, { "symbol": "IGF2", "ensembl": "ENSG00000167244", "n_drug_entries": 2, "n_distinct_drugs": 2, "drugs": { "DUSIGITUMAB": "PHASE_2", "XENTUZUMAB": "PHASE_2" }, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "AB", "bucket": "Advanced Clinical" }, { "modality": "AB", "bucket": "UniProt loc high conf" }, { "modality": "AB", "bucket": "GO CC high conf" }, { "modality": "AB", "bucket": "UniProt SigP or TMHMM" } ] }, { "symbol": "TRIM28", "ensembl": "ENSG00000130726", "n_drug_entries": 0, "n_distinct_drugs": 0, "drugs": {}, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "SM", "bucket": "Med-Quality Pocket" }, { "modality": "PR", "bucket": "UniProt Ubiquitination" }, { "modality": "PR", "bucket": "Database Ubiquitination" }, { "modality": "PR", "bucket": "Half-life Data" } ] }, { "symbol": "SIX1", "ensembl": "ENSG00000126778", "n_drug_entries": 0, "n_distinct_drugs": 0, "drugs": {}, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "PR", "bucket": "UniProt Ubiquitination" }, { "modality": "PR", "bucket": "Database Ubiquitination" } ] }, { "symbol": "SIX2", "ensembl": "ENSG00000170577", "n_drug_entries": 0, "n_distinct_drugs": 0, "drugs": {}, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "PR", "bucket": "Database Ubiquitination" } ] }, { "symbol": "DROSHA", "ensembl": "ENSG00000113360", "n_drug_entries": 0, "n_distinct_drugs": 0, "drugs": {}, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "PR", "bucket": "Database Ubiquitination" }, { "modality": "PR", "bucket": "Half-life Data" } ] }, { "symbol": "DGCR8", "ensembl": "ENSG00000128191", "n_drug_entries": 0, "n_distinct_drugs": 0, "drugs": {}, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "PR", "bucket": "UniProt Ubiquitination" }, { "modality": "PR", "bucket": "Database Ubiquitination" }, { "modality": "PR", "bucket": "Half-life Data" } ] }, { "symbol": "DICER1", "ensembl": "ENSG00000100697", "n_drug_entries": 0, "n_distinct_drugs": 0, "drugs": {}, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "PR", "bucket": "Database Ubiquitination" }, { "modality": "PR", "bucket": "Half-life Data" } ] }, { "symbol": "TP53", "ensembl": "ENSG00000141510", "n_drug_entries": 9, "n_distinct_drugs": 8, "drugs": { "ALRIZOMADLIN": "PHASE_2", "CENERSEN": "PHASE_2", "CONTUSUGENE LADENOVEC": "PHASE_3", "EPRENETAPOPT": "PHASE_3", "IDASANUTLIN": "PHASE_3", "NAVTEMADLIN": "PHASE_3", "SIREMADLIN": "PHASE_2", "TEPRASIRAN": "PHASE_3" }, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "SM", "bucket": "Advanced Clinical" }, { "modality": "SM", "bucket": "Structure with Ligand" }, { "modality": "SM", "bucket": "High-Quality Ligand" }, { "modality": "SM", "bucket": "Med-Quality Pocket" }, { "modality": "SM", "bucket": "Druggable Family" }, { "modality": "PR", "bucket": "UniProt Ubiquitination" }, { "modality": "PR", "bucket": "Database Ubiquitination" }, { "modality": "PR", "bucket": "Small Molecule Binder" }, { "modality": "OC", "bucket": "Advanced Clinical" } ] }, { "symbol": "MYCN", "ensembl": "ENSG00000134323", "n_drug_entries": 0, "n_distinct_drugs": 0, "drugs": {}, "approved": [], "n_approved": 0, "approved_for": {}, "tractability": [ { "modality": "SM", "bucket": "Structure with Ligand" }, { "modality": "PR", "bucket": "Database Ubiquitination" } ] } ], "trials": { "by_antigen": { "WT1": { "n": 153, "n_observational": 33, "n_active": 18, "n_withdrawn": 5, "trials": [ { "nct": "NCT03810651", "title": "Pencil Beam Scanning in Patients With Renal Tumors", "status": "RECRUITING", "last_update": "2026-04-15", "phase": "EARLY_PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04616560", "title": "Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor", "status": "RECRUITING", "last_update": "2026-09-10", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04968990", "title": "Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation", "status": "RECRUITING", "last_update": "2026-04-23", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT05135975", "title": "A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors", "status": "RECRUITING", "last_update": "2025-08-12", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT05384821", "title": "Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)", "status": "RECRUITING", "last_update": "2026-03-18", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT05765084", "title": "Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma", "status": "RECRUITING", "last_update": "2026-06-05", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT05918640", "title": "Lurbinectedin in FET-Fused Tumors", "status": "RECRUITING", "last_update": "2026-09-02", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT05985161", "title": "A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors", "status": "RECRUITING", "last_update": "2026-05-06", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT06456359", "title": "Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor", "status": "RECRUITING", "last_update": "2025-01-13", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT06917885", "title": "CUE-102 in Recurrent Glioblastoma", "status": "RECRUITING", "last_update": "2026-03-05", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT07645469", "title": "FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia", "status": "RECRUITING", "last_update": "2026-08-13", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00001509", "title": "A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor", "status": "COMPLETED", "last_update": "2008-03-04", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00002466", "title": "Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer", "status": "COMPLETED", "last_update": "2013-06-20", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00002515", "title": "Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer", "status": "COMPLETED", "last_update": "2013-06-24", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00002610", "title": "Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors", "status": "COMPLETED", "last_update": "2014-07-25", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00002611", "title": "Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer", "status": "COMPLETED", "last_update": "2021-02-25", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00002673", "title": "Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2010-06-17", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00002854", "title": "High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer", "status": "COMPLETED", "last_update": "2015-08-26", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00003103", "title": "Chemotherapy in Treating Patients With Solid Tumors", "status": "COMPLETED", "last_update": "2013-07-03", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00003107", "title": "Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors", "status": "COMPLETED", "last_update": "2014-09-10", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00003408", "title": "Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer", "status": "COMPLETED", "last_update": "2013-03-26", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00003538", "title": "Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation", "status": "COMPLETED", "last_update": "2014-05-02", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00003597", "title": "Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors", "status": "COMPLETED", "last_update": "2014-07-24", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00003804", "title": "Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor", "status": "UNKNOWN", "last_update": "2014-06-24", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00003883", "title": "Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation", "status": "COMPLETED", "last_update": "2010-04-02", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00003887", "title": "Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2011-11-30", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00003926", "title": "Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors", "status": "TERMINATED", "last_update": "2017-11-29", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00003938", "title": "Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients", "status": "COMPLETED", "last_update": "2012-09-24", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00004157", "title": "Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors", "status": "COMPLETED", "last_update": "2010-04-02", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00004230", "title": "Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2012-06-06", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00005952", "title": "Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors", "status": "COMPLETED", "last_update": "2013-06-20", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00008359", "title": "Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment", "status": "COMPLETED", "last_update": "2013-01-18", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00010283", "title": "Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon", "status": "COMPLETED", "last_update": "2010-04-02", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00014391", "title": "Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2010-04-02", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00019630", "title": "Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors", "status": "COMPLETED", "last_update": "2024-03-04", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00020150", "title": "Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors", "status": "COMPLETED", "last_update": "2015-04-29", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00020527", "title": "Caspofungin Acetate in Treating Children With Fever and Neutropenia", "status": "COMPLETED", "last_update": "2013-06-19", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00020579", "title": "MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma", "status": "COMPLETED", "last_update": "2012-03-15", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00024258", "title": "Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors", "status": "COMPLETED", "last_update": "2015-11-25", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00025103", "title": "Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney", "status": "UNKNOWN", "last_update": "2013-08-02", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00030108", "title": "Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy", "status": "COMPLETED", "last_update": "2012-03-15", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00036712", "title": "Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation", "status": "UNKNOWN", "last_update": "2013-09-20", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00036959", "title": "ABT-751 in Treating Young Patients With Refractory Solid Tumors", "status": "COMPLETED", "last_update": "2012-03-15", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00045292", "title": "Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2010-09-21", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00047138", "title": "Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor", "status": "UNKNOWN", "last_update": "2014-06-24", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00052520", "title": "Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2017-03-29", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00066599", "title": "Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy", "status": "COMPLETED", "last_update": "2013-06-19", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00079222", "title": "Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2020-08-03", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00080873", "title": "Traumeel\u00ae S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2016-01-07", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00118326", "title": "Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease", "status": "COMPLETED", "last_update": "2010-05-14", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00153582", "title": "WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)", "status": "UNKNOWN", "last_update": "2006-02-22", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00153608", "title": "WT1 Peptid Vaccination in Carcinomas", "status": "UNKNOWN", "last_update": "2006-02-14", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00179816", "title": "Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors", "status": "UNKNOWN", "last_update": "2010-10-11", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00179829", "title": "WT1 for the Detection of Minimal Residual Disease", "status": "COMPLETED", "last_update": "2025-02-04", "phase": "PHASE2/PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00187031", "title": "A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor", "status": "COMPLETED", "last_update": "2008-06-04", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00228696", "title": "National Wilm's Tumor Study Late Effects", "status": "WITHDRAWN", "last_update": "2013-11-26", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00270452", "title": "Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome", "status": "COMPLETED", "last_update": "2017-07-02", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00303940", "title": "Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors", "status": "COMPLETED", "last_update": "2012-03-15", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00314925", "title": "Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features", "status": "UNKNOWN", "last_update": "2010-02-25", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00349024", "title": "Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer", "status": "UNKNOWN", "last_update": "2013-09-20", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00352534", "title": "Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor", "status": "COMPLETED", "last_update": "2026-06-03", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00357084", "title": "Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant", "status": "COMPLETED", "last_update": "2010-09-14", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00365768", "title": "Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors", "status": "COMPLETED", "last_update": "2016-09-09", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00369564", "title": "Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer", "status": "COMPLETED", "last_update": "2021-08-11", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00378781", "title": "Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection", "status": "WITHDRAWN", "last_update": "2012-02-24", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00379340", "title": "Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor", "status": "COMPLETED", "last_update": "2026-07-24", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00398138", "title": "Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma", "status": "COMPLETED", "last_update": "2016-03-02", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00433745", "title": "Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy", "status": "COMPLETED", "last_update": "2014-07-08", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00436657", "title": "Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer", "status": "COMPLETED", "last_update": "2012-04-02", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00488592", "title": "Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers", "status": "COMPLETED", "last_update": "2021-07-12", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00509691", "title": "Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy", "status": "COMPLETED", "last_update": "2017-05-09", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00562640", "title": "Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)", "status": "COMPLETED", "last_update": "2023-09-15", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00569283", "title": "Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant", "status": "COMPLETED", "last_update": "2013-03-26", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00617929", "title": "Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant", "status": "TERMINATED", "last_update": "2017-12-28", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00620633", "title": "Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation", "status": "COMPLETED", "last_update": "2021-03-02", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00623077", "title": "MT2004-30: Tomotherapy for Solid Tumors", "status": "TERMINATED", "last_update": "2017-12-05", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00624962", "title": "Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors", "status": "WITHDRAWN", "last_update": "2014-12-11", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00637637", "title": "External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases", "status": "UNKNOWN", "last_update": "2013-08-12", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00665002", "title": "Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms", "status": "COMPLETED", "last_update": "2015-02-27", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00672152", "title": "A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation", "status": "TERMINATED", "last_update": "2013-12-10", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00725283", "title": "Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)", "status": "COMPLETED", "last_update": "2018-08-07", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00769613", "title": "Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections", "status": "UNKNOWN", "last_update": "2013-12-18", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00788125", "title": "Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors", "status": "TERMINATED", "last_update": "2023-07-14", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00831844", "title": "Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors", "status": "COMPLETED", "last_update": "2015-03-30", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00834002", "title": "Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission", "status": "COMPLETED", "last_update": "2010-02-09", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00923910", "title": "Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood", "status": "COMPLETED", "last_update": "2017-04-12", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00945009", "title": "Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor", "status": "COMPLETED", "last_update": "2026-06-03", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00965224", "title": "Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma", "status": "COMPLETED", "last_update": "2024-12-13", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01048892", "title": "Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features", "status": "COMPLETED", "last_update": "2014-01-30", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01051063", "title": "Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy", "status": "COMPLETED", "last_update": "2018-11-29", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01130623", "title": "A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors", "status": "WITHDRAWN", "last_update": "2017-07-02", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01132547", "title": "Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer", "status": "TERMINATED", "last_update": "2015-07-02", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01132911", "title": "A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas", "status": "COMPLETED", "last_update": "2017-07-02", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01169584", "title": "Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients", "status": "COMPLETED", "last_update": "2016-01-21", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01220128", "title": "Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer", "status": "TERMINATED", "last_update": "2021-05-25", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01222780", "title": "To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer", "status": "COMPLETED", "last_update": "2020-01-18", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01236586", "title": "RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia", "status": "WITHDRAWN", "last_update": "2017-07-02", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01265433", "title": "Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy", "status": "COMPLETED", "last_update": "2024-10-09", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01266083", "title": "WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)", "status": "COMPLETED", "last_update": "2024-11-19", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01277744", "title": "Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor", "status": "COMPLETED", "last_update": "2020-01-13", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01291420", "title": "Dendritic Cell Vaccination for Patients with Solid Tumors", "status": "COMPLETED", "last_update": "2024-12-09", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01334060", "title": "WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation", "status": "COMPLETED", "last_update": "2018-09-07", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01440920", "title": "A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients", "status": "COMPLETED", "last_update": "2021-03-08", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01453283", "title": "Tabectedin to Treat Children and Adolescents With Cancer", "status": "COMPLETED", "last_update": "2017-07-02", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01475370", "title": "Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)", "status": "COMPLETED", "last_update": "2021-03-02", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01502410", "title": "Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer", "status": "COMPLETED", "last_update": "2018-06-26", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01513109", "title": "Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia", "status": "UNKNOWN", "last_update": "2012-01-20", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01621542", "title": "Clinical Study of WT2725 in Patients With Advanced Malignancies", "status": "COMPLETED", "last_update": "2019-07-17", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01621724", "title": "WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study", "status": "COMPLETED", "last_update": "2018-10-02", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01640301", "title": "Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant", "status": "TERMINATED", "last_update": "2022-07-14", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01686334", "title": "Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission", "status": "ACTIVE_NOT_RECRUITING", "last_update": "2024-03-12", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01758328", "title": "Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma", "status": "COMPLETED", "last_update": "2025-03-20", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01809392", "title": "Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome", "status": "UNKNOWN", "last_update": "2013-03-12", "phase": "PHASE2/PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01819558", "title": "Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy", "status": "COMPLETED", "last_update": "2015-03-20", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01827137", "title": "WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2024-09-19", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01842139", "title": "Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission", "status": "COMPLETED", "last_update": "2018-03-09", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01995708", "title": "CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2024-02-09", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02076906", "title": "MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors", "status": "COMPLETED", "last_update": "2025-01-01", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02085148", "title": "A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy", "status": "COMPLETED", "last_update": "2024-04-22", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02408016", "title": "Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma", "status": "TERMINATED", "last_update": "2021-09-13", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02452554", "title": "Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma", "status": "COMPLETED", "last_update": "2022-01-13", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02498665", "title": "A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies", "status": "COMPLETED", "last_update": "2023-11-14", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02536183", "title": "A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors", "status": "TERMINATED", "last_update": "2023-08-29", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02550535", "title": "A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients", "status": "COMPLETED", "last_update": "2018-10-02", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02581384", "title": "Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors", "status": "TERMINATED", "last_update": "2021-04-30", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02649829", "title": "Autologous Dendritic Cell Vaccination in Mesothelioma", "status": "COMPLETED", "last_update": "2025-04-29", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02650401", "title": "Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options", "status": "ACTIVE_NOT_RECRUITING", "last_update": "2026-06-23", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02737787", "title": "A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer", "status": "COMPLETED", "last_update": "2023-04-07", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02750995", "title": "Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML", "status": "COMPLETED", "last_update": "2020-11-25", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02770820", "title": "Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia", "status": "TERMINATED", "last_update": "2021-10-29", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02867592", "title": "Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors", "status": "ACTIVE_NOT_RECRUITING", "last_update": "2026-08-28", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02895412", "title": "Infection and Tumour Antigen Cellular Therapy", "status": "UNKNOWN", "last_update": "2016-09-09", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02982941", "title": "Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors", "status": "COMPLETED", "last_update": "2022-02-08", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT03114631", "title": "Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer", "status": "COMPLETED", "last_update": "2019-12-03", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT03149003", "title": "A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy", "status": "COMPLETED", "last_update": "2023-11-15", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT03311334", "title": "A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors", "status": "TERMINATED", "last_update": "2024-04-18", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT03478462", "title": "Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas", "status": "ACTIVE_NOT_RECRUITING", "last_update": "2026-03-18", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT03507491", "title": "Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors", "status": "COMPLETED", "last_update": "2024-10-04", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT03761914", "title": "Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers", "status": "COMPLETED", "last_update": "2024-11-19", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT03892330", "title": "Combination Therapy of Anthracyclines for Children With Nephroblastoma", "status": "NOT_YET_RECRUITING", "last_update": "2019-03-27", "phase": "PHASE4", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04040231", "title": "Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma", "status": "COMPLETED", "last_update": "2025-05-13", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04168788", "title": "Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL", "status": "COMPLETED", "last_update": "2026-06-29", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04229979", "title": "Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2", "status": "ACTIVE_NOT_RECRUITING", "last_update": "2025-10-01", "phase": "PHASE3", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04284228", "title": "Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT", "status": "UNKNOWN", "last_update": "2024-01-16", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04758455", "title": "The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence", "status": "UNKNOWN", "last_update": "2021-02-17", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04814758", "title": "DWI in the Diagnosis of Histological Types of Nephroblastoma in Children", "status": "UNKNOWN", "last_update": "2021-03-24", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04837196", "title": "Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen", "status": "COMPLETED", "last_update": "2025-08-08", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04911621", "title": "Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma", "status": "COMPLETED", "last_update": "2026-06-05", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT05000801", "title": "Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia", "status": "UNKNOWN", "last_update": "2021-08-20", "phase": "NA", "study_type": "INTERVENTIONAL" }, { "nct": "NCT05360680", "title": "A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers", "status": "COMPLETED", "last_update": "2026-01-22", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT05964361", "title": "First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients", "status": "COMPLETED", "last_update": "2026-06-08", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT06172634", "title": "A Single-center Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow-derived DCs(CellgramDC-WT1) and Immune Checkpoint Inhibitors in Patients With Metastatic Pancreatic Cancer Who Have Failed First-line or More Standard Chemotherapy", "status": "UNKNOWN", "last_update": "2023-12-15", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT07796061", "title": "Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)", "status": "NOT_YET_RECRUITING", "last_update": "2026-08-31", "phase": "PHASE1", "study_type": "INTERVENTIONAL" } ], "cell_therapy": { "n": 15, "n_observational": 0, "n_active": 1, "n_withdrawn": 0, "trials": [ { "nct": "NCT07645469", "title": "FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia", "status": "RECRUITING", "last_update": "2026-08-13", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00003887", "title": "Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2011-11-30", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00562640", "title": "Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)", "status": "COMPLETED", "last_update": "2023-09-15", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00620633", "title": "Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation", "status": "COMPLETED", "last_update": "2021-03-02", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00769613", "title": "Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections", "status": "UNKNOWN", "last_update": "2013-12-18", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT00965224", "title": "Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma", "status": "COMPLETED", "last_update": "2024-12-13", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01513109", "title": "Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia", "status": "UNKNOWN", "last_update": "2012-01-20", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01621724", "title": "WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study", "status": "COMPLETED", "last_update": "2018-10-02", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01640301", "title": "Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant", "status": "TERMINATED", "last_update": "2022-07-14", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01758328", "title": "Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma", "status": "COMPLETED", "last_update": "2025-03-20", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02408016", "title": "Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma", "status": "TERMINATED", "last_update": "2021-09-13", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02550535", "title": "A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients", "status": "COMPLETED", "last_update": "2018-10-02", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02770820", "title": "Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia", "status": "TERMINATED", "last_update": "2021-10-29", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02895412", "title": "Infection and Tumour Antigen Cellular Therapy", "status": "UNKNOWN", "last_update": "2016-09-09", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04284228", "title": "Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT", "status": "UNKNOWN", "last_update": "2024-01-16", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" } ] }, "synonyms_searched": [ "WT1", "WT1 vaccine", "galinpepimut", "WT1 peptide" ] }, "VEGFR": { "n": 3, "n_observational": 0, "n_active": 2, "n_withdrawn": 0, "trials": [ { "nct": "NCT05135975", "title": "A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors", "status": "RECRUITING", "last_update": "2025-08-12", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01502410", "title": "Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer", "status": "COMPLETED", "last_update": "2018-06-26", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02867592", "title": "Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors", "status": "ACTIVE_NOT_RECRUITING", "last_update": "2026-08-28", "phase": "PHASE2", "study_type": "INTERVENTIONAL" } ], "cell_therapy": { "n": 0, "n_observational": 0, "n_active": 0, "n_withdrawn": 0, "trials": [] }, "synonyms_searched": [ "VEGFR", "sorafenib", "sunitinib", "cabozantinib" ] }, "IGF-1R": { "n": 1, "n_observational": 0, "n_active": 0, "n_withdrawn": 0, "trials": [ { "nct": "NCT00831844", "title": "Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors", "status": "COMPLETED", "last_update": "2015-03-30", "phase": "PHASE2", "study_type": "INTERVENTIONAL" } ], "cell_therapy": { "n": 0, "n_observational": 0, "n_active": 0, "n_withdrawn": 0, "trials": [] }, "synonyms_searched": [ "IGF-1R", "IGF1R", "ganitumab" ] }, "PD-1": { "n": 7, "n_observational": 0, "n_active": 1, "n_withdrawn": 0, "trials": [ { "nct": "NCT02737787", "title": "A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer", "status": "COMPLETED", "last_update": "2023-04-07", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT03311334", "title": "A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors", "status": "TERMINATED", "last_update": "2024-04-18", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT03761914", "title": "Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers", "status": "COMPLETED", "last_update": "2024-11-19", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04040231", "title": "Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma", "status": "COMPLETED", "last_update": "2025-05-13", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04483778", "title": "B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults", "status": "ACTIVE_NOT_RECRUITING", "last_update": "2026-04-28", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04837196", "title": "Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen", "status": "COMPLETED", "last_update": "2025-08-08", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT05302921", "title": "Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors", "status": "COMPLETED", "last_update": "2025-01-01", "phase": "PHASE2", "study_type": "INTERVENTIONAL" } ], "cell_therapy": { "n": 1, "n_observational": 0, "n_active": 1, "n_withdrawn": 0, "trials": [ { "nct": "NCT04483778", "title": "B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults", "status": "ACTIVE_NOT_RECRUITING", "last_update": "2026-04-28", "phase": "PHASE1", "study_type": "INTERVENTIONAL" } ] }, "synonyms_searched": [ "PD-1", "nivolumab", "pembrolizumab" ] }, "B7-H3": { "n": 3, "n_observational": 1, "n_active": 2, "n_withdrawn": 0, "trials": [ { "nct": "NCT04897321", "title": "B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)", "status": "RECRUITING", "last_update": "2026-05-19", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT07172958", "title": "Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)", "status": "RECRUITING", "last_update": "2026-08-13", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT02982941", "title": "Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors", "status": "COMPLETED", "last_update": "2022-02-08", "phase": "PHASE1", "study_type": "INTERVENTIONAL" } ], "cell_therapy": { "n": 2, "n_observational": 0, "n_active": 2, "n_withdrawn": 0, "trials": [ { "nct": "NCT04897321", "title": "B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)", "status": "RECRUITING", "last_update": "2026-05-19", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT07172958", "title": "Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)", "status": "RECRUITING", "last_update": "2026-08-13", "phase": "PHASE1", "study_type": "INTERVENTIONAL" } ] }, "synonyms_searched": [ "B7-H3", "CD276" ] } }, "by_drug": { "GALINPEPIMUT-S": { "n": 6, "n_observational": 1, "n_active": 1, "n_withdrawn": 0, "trials": [ { "nct": "NCT01265433", "title": "Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy", "status": "COMPLETED", "last_update": "2024-10-09", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01266083", "title": "WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)", "status": "COMPLETED", "last_update": "2024-11-19", "phase": "PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT01827137", "title": "WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation", "status": "COMPLETED", "last_update": "2024-09-19", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT03761914", "title": "Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers", "status": "COMPLETED", "last_update": "2024-11-19", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04040231", "title": "Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma", "status": "COMPLETED", "last_update": "2025-05-13", "phase": "PHASE1", "study_type": "INTERVENTIONAL" }, { "nct": "NCT04229979", "title": "Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2", "status": "ACTIVE_NOT_RECRUITING", "last_update": "2025-10-01", "phase": "PHASE3", "study_type": "INTERVENTIONAL" } ] }, "OMBIPEPIMUT-S": { "n": 1, "n_observational": 0, "n_active": 0, "n_withdrawn": 0, "trials": [ { "nct": "NCT03311334", "title": "A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors", "status": "TERMINATED", "last_update": "2024-04-18", "phase": "PHASE1/PHASE2", "study_type": "INTERVENTIONAL" } ] } } } }